GSK plc ADR sell Morgan Stanley
Start price
14.01.26
/
50%
€43.20
Target price
14.01.27
-
Performance (%)
12.04%
Price
17.04.26
€49.60
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 12.04%. This prediction currently runs until 14.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | -0.800% | -0.800% |
| iShares Core DAX® | 3.593% | 6.427% |
| iShares Nasdaq 100 | 5.810% | 6.381% |
| iShares Nikkei 225® | 4.075% | 9.307% |
| iShares S&P 500 | 4.142% | 4.938% |
Comments by Morgan_Stanley for this prediction
In the thread GSK plc ADR diskutieren
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for GSK provided by MarketBeat